These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 6315818

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The role of cyclic AMP in modulating cytotoxic T lymphocytes. I. In-vivo-generated cytotoxic lymphocytes, but not in vitro-generated cytotoxic lymphocytes, are inhibited by cyclic AMP-active agents.
    Plaut M.
    J Immunol; 1979 Aug; 123(2):692-701. PubMed ID: 222842
    [No Abstract] [Full Text] [Related]

  • 3. Increased responsiveness to adenosine 3'5'-cyclic monophosphate-active agents during the immune response in vivo.
    Plaut M.
    Immunopharmacology; 1981 Jun; 3(2):107-16. PubMed ID: 6265406
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of cytolytic T lymphocyte maturation with ornithine, arginine, and putrescine.
    Susskind BM, Chandrasekaran J.
    J Immunol; 1987 Aug 01; 139(3):905-12. PubMed ID: 2955052
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Hemolytic plaque formation by leukocytes in vitro. Control by vasoactive hormones.
    Melmon KL, Bourne HR, Weinstein Y, Shearer GM, Kram J, Bauminger S.
    J Clin Invest; 1974 Jan 01; 53(1):13-21. PubMed ID: 4357609
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Different effect of prostaglandin E2 on B-cell activation by two distinct B-cell differentiation factors, B151-TRF1/IL-5 and B151-TRF2: selective inhibition of B151-TRF2-induced antibody response through increases in intracellular cyclic AMP levels.
    Ishihara K, Ono S, Takahama Y, Hirayama F, Hirano H, Itoh K, Dobashi K, Murakami S, Katoh Y, Yamaguchi M.
    Immunology; 1989 Oct 01; 68(2):154-62. PubMed ID: 2553585
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of ornithine decarboxylase and S-adenosylmethionine decarboxylase activities of S49 lymphoma cells by agents increasing cyclic AMP.
    Honeysett JM, Insel PA.
    J Cyclic Nucleotide Res; 1981 Oct 01; 7(5):321-32. PubMed ID: 6284819
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Chronic morphine treatment suppresses CTL-mediated cytolysis, granulation, and cAMP responses to alloantigen.
    Carpenter GW, Garza HH, Gebhardt BM, Carr DJ.
    Brain Behav Immun; 1994 Sep 01; 8(3):185-203. PubMed ID: 7865891
    [Abstract] [Full Text] [Related]

  • 15. Modulation of F1 cytotoxic potentials by GvHR. Host- and donor-derived cytotoxic lymphocytes arise in the unirradiated F1 host spleens under the condition of GvHR-associated immunosuppression.
    Kubota E, Ishikawa H, Saito K.
    J Immunol; 1983 Sep 01; 131(3):1142-8. PubMed ID: 6604089
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cloned cytotoxic T lymphocytes as target cells. II. Polarity of lysis revisited.
    Gorman K, Liu CC, Blakely A, Young JD, Torbett BE, Clark WR.
    J Immunol; 1988 Oct 01; 141(7):2211-5. PubMed ID: 3262651
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.